A New England hospital system is assessing with real patients a point-of-care test for Covid-19 viruses that returns results in about an hour. . . . → Read More: Hospitals Testing Fast Covid-19 Diagnostic
|
|||||
|
       
  |
Results of a clinical trial show contact lenses that focus light on multiple areas of the retina reduce near-sightedness in children. . . . → Read More: Muti-Focus Contact Lenses Slow Children’s Myopia 
A clinical trial is underway assessing a drug approved for a rare inherited disease as a treatment for people hospitalized with pneumonia from Covid-19 infections. . . . → Read More: Trial Testing Rare Disease Drug for Covid-19 Pneumonia 
Discoveries in a university lab that enable detection of Covid-19 infections from a person’s breath are being licensed for development by a biotechnology company. . . . → Read More: Breath Analysis Sensor Licensed to Detect Covid-19 
Seven new vaccine projects got underway last week, raising the total to 164, with six more vaccines reaching clinical trials now totaling 41. . . . → Read More: Covid-19 Vaccines, Therapies – 10 August 2020 
The genome of the Asian giant hornet, a species threatening bees and humans, was analyzed, with the data released by the Agricultural Research Service. . . . → Read More: Giant Hornet Genome Sequenced 
A clinical trial testing stem cells from human placentas as a treatment for Covid-19 infections is expanding to three more sites in California. . . . → Read More: Grant Funds Placenta Stem Cell Trial Sites for Covid-19 
National Institutes of Health is beginning clinical trials of experimental antibody therapies to treat Covid-19 infections in people with symptoms ranging from mild to severe. . . . → Read More: NIH Begins Covid-19 Antibody Trials 
Researchers from University of California in Los Angeles and Apple Corp. are beginning a study of wearable and home technologies to detect depression. . . . → Read More: UCLA, Apple Partner on Depression Study 
A new company developing treatments to relieve allergic reactions with reprogrammed antibodies began work and is raising $10 million in its first venture funding round. . . . → Read More: New Allergy Biotech Launches, Raises $10M |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
